Renal Injury during Long-Term Crizotinib Therapy

Crizotinib is highly effective against anaplastic lymphoma kinase-positive and c-ros oncogen1-positive non-small cell lung cancer. Renal dysfunction is associated with crizotinib therapy but the mechanism is unknown. Here, we report a case of anaplastic lymphoma kinase positive non-small cell lung c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Mol Sci
Hauptverfasser: Yasuma, Taro, Kobayashi, Tetsu, D’Alessandro-Gabazza, Corina N., Fujimoto, Hajime, Ito, Kentaro, Nishii, Yoichi, Nishihama, Kota, Baffour Tonto, Prince, Takeshita, Atsuro, Toda, Masaaki, Gabazza, Esteban C., Taguchi, Osamu, Yonemura, Shigenori, Hataji, Osamu
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2018
Schlagworte:
Communication
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6213486/
https://ncbi.nlm.nih.gov/pubmed/30257437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19102902
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge